Graham Capital Management L.P. Has $2.32 Million Holdings in The Clorox Company $CLX

Key Points

• Graham Capital Management L.P. increased its holdings in The Clorox Company by 34.8%, owning 15,720 shares valued at $2.3 million as of its latest SEC filing.
• Clorox recently announced a quarterly dividend of $1.24, representing an annualized yield of 4.2%, an increase from the previous dividend of $1.22.
• Analysts have mixed outlooks on Clorox stock, with a consensus rating of "Reduce" and an average target price of $143.36.

Graham Capital Management L.P. raised its position in The Clorox Company (NYSE:CLX - Free Report) by 34.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,720 shares of the company's stock after buying an additional 4,062 shares during the quarter. Graham Capital Management L.P.'s holdings in Clorox were worth $2,315,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Comerica Bank grew its holdings in Clorox by 15.7% in the 4th quarter. Comerica Bank now owns 36,196 shares of the company's stock valued at $5,879,000 after buying an additional 4,908 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in shares of Clorox by 1.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 14,206 shares of the company's stock worth $2,307,000 after purchasing an additional 201 shares in the last quarter. AlTi Global Inc. acquired a new stake in shares of Clorox during the 4th quarter worth $212,000. AXA S.A. grew its holdings in shares of Clorox by 114.0% during the 4th quarter. AXA S.A. now owns 91,086 shares of the company's stock worth $14,793,000 after purchasing an additional 48,524 shares in the last quarter. Finally, Aptus Capital Advisors LLC acquired a new stake in shares of Clorox during the 4th quarter worth $801,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. JPMorgan Chase & Co. reduced their target price on Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Wells Fargo & Company reduced their target price on Clorox from $138.00 to $130.00 and set an "equal weight" rating on the stock in a report on Friday. Morgan Stanley reduced their target price on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Barclays dropped their price objective on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Finally, Jefferies Financial Group dropped their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research report on Thursday, June 26th. One research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Clorox has a consensus rating of "Reduce" and an average price target of $142.64.

Clorox Trading Up 2.0%

Clorox stock traded up $2.45 during trading hours on Friday, hitting $127.08. The stock had a trading volume of 3,231,696 shares, compared to its average volume of 1,756,627. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The stock has a market cap of $15.54 billion, a price-to-earnings ratio of 19.49, a P/E/G ratio of 1.00 and a beta of 0.52. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The business's 50 day simple moving average is $124.17 and its 200-day simple moving average is $133.47.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business's quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the company earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were paid a dividend of $1.24 per share. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a yield of 3.9%. The ex-dividend date of this dividend was Wednesday, August 13th. Clorox's payout ratio is 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.